The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 study of pivekimab sunirine (PVEK, IMGN632) in combination with venetoclax/azacitidine for patients with newly diagnosed CD123-positive acute myeloid leukemia.
 
Naval Guastad Daver
Consulting or Advisory Role - Abbvie; Agios; Amgen; Arog; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; Immunogen; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; SERVIER; Shattuck Labs; Stemline/Menarini; Syndax; Trillium Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); FATE Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Hanmi (Inst); Immunogen (Inst); Kite, a Gilead company (Inst); Novimmune (Inst); Pfizer (Inst); Servier (Inst); Trillium Therapeutics (Inst); Trovagene (Inst)
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Astellas Oncology; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Kura Oncology; Menarini Group; Nerviano Medical Sciences; Novartis; Otsuka; Pfizer; Ryvu Therapeutics; Takeda
Speakers' Bureau - Abbvie; Astellas Oncology; Janssen; Jazz Pharmaceuticals; Pfizer
Research Funding - Abbvie; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Menarini Group; Novartis; Pfizer; Takeda
 
Jessica K. Altman
Consulting or Advisory Role - Abbvie; Astellas Pharma; BioSight; Bluebird Bio; Curio Science; Daiichi Sankyo/Lilly; Gilead Sciences; Gilead Sciences; GlycoMimetics; Kura Oncology; Stemline Therapeutics; Syros Pharmaceuticals
Research Funding - Abbvie (Inst); Agios (Inst); ALX Oncology (Inst); Amgen (Inst); Amphivena (Inst); Aprea AB (Inst); Aptose Biosciences (Inst); Astellas Pharma (Inst); Biosight (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cyclacel (Inst); Fujifilm (Inst); Immunogen (Inst); Kartos Therapeutics (Inst); Kura Oncology (Inst); Kura Oncology (Inst); Loxo (Inst); Pfizer (Inst); Telios (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Biosight; Daiichi Sankyo
Other Relationship - Imedex/HMP; NCI; Peerview; Peerview
 
Anjali S. Advani
Consulting or Advisory Role - Amgen; Beam Therapeutics; Beam Therapeutics; Glycomimetics; Jazz Pharmaceuticals; Kite, a Gilead company; Kura Oncology; Nkarta; Novartis; Pfizer; Seagen; SERVIER; Taiho Oncology
Research Funding - Amgen (Inst); Beam Therapeutics (Inst); Glycomimetics (Inst); Immunogen (Inst); Incyte (Inst); Kite/Gilead (Inst); Macrogenics (Inst); OBI Pharma (Inst); Pfizer (Inst); Pfizer (Inst); Seagen (Inst); SERVIER (Inst)
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Daiichi Sankyo/UCB Japan; Gilead Sciences; GlaxoSmithKline; Immunogen; Janssen; Kite/Gilead; Kura Oncology; Novartis; Nuprobe; Qiagen; Rigel; Schrodinger; Sellas Life Sciences; Sumitomo Pharma Oncology; Syndax
Speakers' Bureau - Astellas Pharma; DAVA Pharmaceuticals; Pfizer
Other Relationship - Abbvie/Genentech; Gilead Sciences; Gilead Sciences
 
Sylvain Garciaz
No Relationships to Disclose
 
Giovanni Martinelli
Consulting or Advisory Role - Abbvie; Celgene; Daichii Sankyo; Incyte; Jazz Pharmaceuticals; Pfizer; Roche
Speakers' Bureau - Jazz Pharmaceuticals; Menarini; Novartis
Research Funding - Daichii Sankyo; Pfizer
Travel, Accommodations, Expenses - Abbvie; daichii sankyo; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Pfizer
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Amgen; Argenx; AstraZeneca; Bluebird Bio; Blueprint Medicines; Bristol-Myers Squibb; Daiichi Sankyo; Ellipsis Pharma; GlaxoSmithKline; Janssen; Jasper Therapeutics; Jazz Pharmaceuticals; Molecular Partners; Novartis; Pfizer; Roche; Syndax; Takeda
Research Funding - Janssen
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Abbvie; Adicet Bio; BerGenBio; BiolineRx; Bristol-Myers Squibb/Celgene/Juno; Genentech; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Kronos; Kura Oncology; Orum Therapeutics; Pfizer; Stemline Therapeutics
Research Funding - Amgen (Inst); Aptevo Therapeutics; Arog (Inst); Celgene; Immunogen (Inst); Janssen Research & Development (Inst); Jazz Pharmaceuticals (Inst); Kite/Gilead; Kura Oncology; Macrogenics (Inst); Pfizer; Selvita (Inst)
 
Kebede Begna
Consulting or Advisory Role - Novartis/Pfizer
 
Monia Lunghi
No Relationships to Disclose
 
Uwe Platzbecker
Honoraria - Abbvie; Celgene/Jazz; Curis; Geron; Janssen
Consulting or Advisory Role - BMS GmbH & Co. KG; Celgene/Jazz; Novartis
Research Funding - Amgen (Inst); BerGenBio (Inst); Celgene (Inst); Curis (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - part of a patent for a TFR-2 antibody (Rauner et al. Nature Metabolics 2019)
Travel, Accommodations, Expenses - Celgene
 
Paresh Vyas
Stock and Other Ownership Interests - Auron Therapeutics
Honoraria - Abbvie; Astellas Oncology; Gilead Sciences; Jazz Pharmaceuticals; Pfizer
Consulting or Advisory Role - Abbvie
Research Funding - Bristol-Myers Squibb
 
Patrick William Burke
Consulting or Advisory Role - Eisai (I); Lilly (I); Seagen (I)
Research Funding - Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - DAVA Pharmaceuticals
 
Antonio Curti
Consulting or Advisory Role - Abbvie; Novartis; Pfizer
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; servier; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Lauris Gastaud
No Relationships to Disclose
 
Christoph Schliemann
Honoraria - Abbvie; AstraZeneca; Jazz Pharmaceuticals; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Celgene; Jazz Pharmaceuticals; Laboratories Delbert; Novartis; Pfizer; Roche; Takeda
Research Funding - AngioBiomed (Inst); Boehringer Ingelheim (Inst); Jazz Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb/Celgene; Celgene; Pfizer; PharmaMar
 
Benjamin Oshrine
Employment - ImmunoGen
Stock and Other Ownership Interests - ImmunoGen
 
David Andrew Sallman
Consulting or Advisory Role - Abbvie; Agios; AvenCell; Bristol-Myers Squibb; Dark Blue Therapeutics; Gilead Sciences; Janssen; Jasper Therapeutics; Kite, a Gilead company; Molecular Partners; Nkarta; Novartis; Orbital Therapeutics; Servier; Syndax; Syndax; Syros Pharmaceuticals; Takeda; Zentalis
Speakers' Bureau - Incyte
Research Funding - Aprea Therapeutics (Inst); Jazz Pharmaceuticals